As of December 31, 2008, Omrix
operates as a stand-alone entity reporting through ETHICON, Inc.,
a Johnson & Johnson company and leading provider of suture,
mesh, hemostats and other products for a wide range of surgical
procedures. Since 2003, OMRIX has partnered its biosurgical product
line for hemostasis with Johnson & Johnson’s Ethicon division,
a leader in the market place. This allows each company to do what
it does best, utilizing OMRIX’s know-how and manufacturing
capabilities, and leveraging Johnson & Johnson’s sales
and marketing leadership. |